Monoclonal antibodies that recognize TIGIT and inhibit its suppressive activity on T-cells are provided as well as pharmaceutical compositions including them and methods for their use in cancer immunotherapy and in diagnosis and treatment of immune disorders.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10946095 Antibodies specific to human T-cell immunoglobulin and ITIM domain (TIGIT)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

US Patent 10946095 Antibodies specific to human T-cell immunoglobulin and ITIM domain (TIGIT)

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 10946095 Antibodies specific to human T-cell immunoglobulin and ITIM domain (TIGIT)